Long-term efficacy of trilostane for Cushing's syndrome due to adrenocorticotropin-independent bilateral macronodular adrenocortical hyperplasia

Internal Medicine

Volumn 50, Issue 21, 2011, Pages 2621-2625

  Obata, Yoshinari ^a   Yamada, Yuya ^a   Baden, Megu Yamaguchi ^a   Hosokawa, Yoshiya ^a   Saisho, Kenji ^a   Tamba, Sachiko ^a   Yamamoto, Koji ^a   Matsuzawa, Yuji ^a  

^a SUMITOMO HOSPITAL   (Japan)

Author keywords

Adrenocorticotropin independent bilateral macronodular adrenocortical hyperplasia (AIMAH); Cushing's syndrome; Trilostane

Indexed keywords

CORTICOTROPIN; GLUCOCORTICOID; HYDROCORTISONE; TRILOSTANE;

ADRENAL GLAND; AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DRUG EFFICACY; DRUG RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; MALE; MOON FACE; OBESITY; STEROIDOGENESIS;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; CUSHING SYNDROME; DIHYDROTESTOSTERONE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 80455167989     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5578     Document Type: Article

References (23)

1. Kirschner MA, Powell RD, Lipsett MB. Cushing's syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor. J Clin Endocrinol Metab 24: 947-955, 1964.
2. Lacroix A, Ndiaye N, Tremblay J, Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 22: 75-110, 2001.
3. Lieberman SA, Eccleshall TR, Feldman D. ACTH-independent massive bilateral disease (AIMBAD): a subtype of Cushing's syndrome with major diagnostic and therapeutic implications. Eur J Endocrinol 131: 67-73, 1994.
4. Stratakis CA, Kirschner LS. Clinical and genetic analysis of primary bilateral adrenal diseases (micro-and macronodular disease) leading to Cushing syndrome. Horm Metab Res 30: 456-463, 1998.
5. Komanicky P, Spark RF, Melby JC. Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis. J Clin Endocrinol Metab 47: 1042-1051, 1978.
6. Ohashi A, Yamada Y, Sakaguchi K, Inoue T, Kubo M, Fushimi H. A natural history of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) from preclinical to clinically overt Cushing's syndrome. Endocr J 48: 677-683, 2001.
7. Aiba M, Hirayama A, Iri H, et al. Adrenocorticotropic hormoneindependent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing's syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature. Am J Clin Pathol 96: 334-340, 1991.
8. Mircescu H, Jilwan J, N'Diaye N, et al. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? J Clin Endocrinol Metab 85: 3531-3536, 2000.
9. Bertagna X, Groussin L, Luton JP, Bertherat J. Aberrant receptormediated Cushing's syndrome. Horm Res 59: 99-103, 2003.
10. Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J. Cushing's syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab 15: 375-382, 2004.
11. Yamada Y, Sakaguchi K, Inoue T, et al. Preclinical Cushing's syndrome due to adrenocorticotropin-independent bilateral adrenocortical macronodular hyperplasia with concurrent excess of glucoand mineralocorticoids. Intern Med 36: 628-632, 1997.
12. Wada N, Kubo M, Kijima H, et al. Adrenocorticotropinindependent bilateral macronodular adrenocortical hyperplasia: immunohistochemical studies of steroidogenic enzymes and postoperative course in two men. Eur J Endocrinol 134: 583-587, 1996.
13. Kageyama Y, Ishizaka K, Iwashina M, Sasano H, Kihara K. A case of ACTH-independent bilateral macronodular adrenal hyperplasia successfully treated by subtotal resection of the adrenal glands: four-year follow-up. Endocr J 49: 227-229, 2002.
14. Lamas C, Alfaro JJ, Lucas T, Lecumberri B, Barceló B, Estrada J. Is unilateral adrenalectomy an alternative treatment for ACTHindependent macronodular adrenal hyperplasia? Long-term followup of four cases. Eur J Endocrinol 146: 237-240, 2002.
15. Iacobone M, Albiger N, Scaroni C, et al. The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH). World J Surg 32: 882-889, 2008.
16. Okada M, Kamiya Y, Jinno Y, Kato N, Kawaguchi M, Fujinami T. Cushing's syndrome caused by bilateral adrenocortical macronodular hyperplasia was succesfully treated with Trilostane. Clin Endocrinol 46: 97-100, 1998 (in Japanese).
17. Nagai M, Narita I, Omori K, Komura S, Arakawa M. Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia treated with mitotane. Intern Med 38: 969-973, 1999.
18. Omori N, Nomura K, Omori K, Takano K, Obara T. Rational, effective metyrapone treatment of ACTH-independent bilateral macronodular adrenocortical hyperplasia (AIMAH). Endocr J 48: 665-669, 2001.
19. Reznik Y, Allali-Zerah V, Chayvialle JA, et al. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med 327: 981-986, 1992.
20. Daidoh H, Morita H, Hanafusa J, et al. In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 49: 403-409, 1998.
21. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 337: 1429-1434, 1997.
22. Lacroix A, Hamet P, Boutin JM. Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome. N Engl J Med 341: 1577-1581, 1999.
23. Oki K, Yamane K, Nakanishi S, Nakashima R, Jitsuiki K, Kohno N. Improvement of hypercortisolism by N-blocker therapy in subclinical Cushing's syndrome associated with ACTH-independent macronodular adrenocortical hyperplasia. Endocrine 36: 372-376, 2009.